dihydroxyphenylalanine has been researched along with Bright Disease in 2 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karpenko, EI | 1 |
| Deĭneko, VS | 1 |
| Midelauri, BG | 1 |
2 other studies available for dihydroxyphenylalanine and Bright Disease
| Article | Year |
|---|---|
[Excretion of catecholamines and their precursors and indices of electrolyte balance in patients with chronic glomerulonephritis].
Topics: Adolescent; Adult; Catecholamines; Chronic Disease; Dihydroxyphenylalanine; Dopamine; Epinephrine; G | 1972 |
[Urinary excretion of catecholamines and sodium and potassium levels in serum and erythrocytes in patients with renal hypertension].
Topics: Adrenocortical Hyperfunction; Catecholamines; Chronic Disease; Dihydroxyphenylalanine; Dopamine; Epi | 1967 |